XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statement of Equity Statement - USD ($)
$ in Thousands
Total
Common Stock Par Value
Additional Paid-In Capital
Treasury Stock
Accumulated Other  Comprehensive Income (Loss)
Unrealized Gain (Loss) on Investment
Retained Deficit
Noncontrolling Interest
Balance at beginning of period at Dec. 31, 2021 $ 98,563 $ 1,301 $ 475,624 $ (19,957) $ (46,932) $ 0 $ (310,332) $ (1,141)
Net income, retained deficit             7,720  
Net income 7,719             (1)
Translation adjustment, net of taxes 192       192      
Comprehensive loss 7,911              
Equity compensation expense 1,104   1,104          
Other (676) 7 (673)         (10)
Balance at end of period at Mar. 31, 2022 106,902 1,308 476,055 (19,957) (46,740) 0 (302,612) (1,152)
Balance at beginning of period at Dec. 31, 2021 98,563 1,301 475,624 (19,957) (46,932) 0 (310,332) (1,141)
Net income, retained deficit 9,743              
Net income 9,700              
Other comprehensive income (loss) (306)              
Comprehensive loss 2,299              
Balance at end of period at Sep. 30, 2022 101,756 1,318 476,530 (19,957) (54,027) (306) (300,589) (1,213)
Balance at beginning of period at Mar. 31, 2022 106,902 1,308 476,055 (19,957) (46,740) 0 (302,612) (1,152)
Net income, retained deficit             1,745  
Net income 1,725             (20)
Translation adjustment, net of taxes (3,414)       (3,414)     0
Comprehensive loss (1,689)              
Equity compensation expense 1,159   1,159         0
Other (836)   (833)         (9)
Balance at end of period at Jun. 30, 2022 105,536 1,314 476,381 (19,957) (50,154) 0 (300,867) (1,181)
Net income, retained deficit 278           278  
Net income 256             (22)
Translation adjustment, net of taxes (3,873)       (3,873)     0
Other comprehensive income (loss) (306)         (306)    
Comprehensive loss (3,923)              
Equity compensation expense 1,098   1,098         0
Other (955)   (949)         (10)
Balance at end of period at Sep. 30, 2022 101,756 1,318 476,530 (19,957) (54,027) (306) (300,589) (1,213)
Balance at beginning of period at Dec. 31, 2022 106,397 1,318 477,820 (19,957) (48,991) (72) (302,493) (1,228)
Net income, retained deficit             6,040  
Net income 6,033             (7)
Translation adjustment, net of taxes 1,421              
Other comprehensive income (loss) 121              
Comprehensive loss 7,575              
Equity compensation expense [1] 3,514   3,514          
Other (1,333) 7 (1,341)         1
Balance at end of period at Mar. 31, 2023 116,153 1,325 479,993 (19,957) (47,570) 49 (296,453) (1,234)
Balance at beginning of period at Dec. 31, 2022 106,397 1,318 477,820 (19,957) (48,991) (72) (302,493) (1,228)
Net income, retained deficit 29,675              
Net income 29,650              
Other comprehensive income (loss) 474              
Comprehensive loss 29,840              
Balance at end of period at Sep. 30, 2023 141,137 1,332 482,709 (19,957) (49,275) 402 (272,818) (1,256)
Balance at beginning of period at Mar. 31, 2023 116,153 1,325 479,993 (19,957) (47,570) 49 (296,453) (1,234)
Net income, retained deficit             18,215  
Net income 18,197             (18)
Translation adjustment, net of taxes 1,045       1,045     0
Other comprehensive income (loss) 207              
Comprehensive loss 19,449              
Equity compensation expense 1,507   1,507         0
Other (52) 2 (52)         (2)
Balance at end of period at Jun. 30, 2023 137,057 1,327 481,448 (19,957) (46,525) 256 (278,238) (1,254)
Net income, retained deficit 5,420           5,420  
Net income 5,420             0
Translation adjustment, net of taxes (2,750)       (2,750)     0
Other comprehensive income (loss) 146         146    
Comprehensive loss 2,816              
Equity compensation expense 1,396   1,396         0
Other (132) 5 (135)         (2)
Balance at end of period at Sep. 30, 2023 $ 141,137 $ 1,332 $ 482,709 $ (19,957) $ (49,275) $ 402 $ (272,818) $ (1,256)
[1] Equity-based compensation for the three months ended March 31, 2023 includes $2.3 million for a portion of short-term incentive compensation that was settled through grants of restricted stock units rather than cash.